Cytoplasmic accumulation of peanut agglutinin-binding glycoconjugates in the cells of primary melanoma correlates with clinical outcome

Human Pathology

Volumn 30, Issue 5, 1999, Pages 556-561

  Cochran, Alistair J ^a   Wen, Duan Ren ^b   Berthier Vergnes, Odile ^b   Bailly, Christiane ^b   Doré, Jean Francois ^b   Bérard, Frederic ^b   Moulin, Georges ^b   Thomas, Luc ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Glycoconjugates; Melanoma; Prognosis

Indexed keywords

GLYCOCONJUGATE; N ACETYLGALACTOSAMINE; PEANUT AGGLUTININ;

ARTICLE; CANCER STAGING; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; GOLGI COMPLEX; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN TISSUE; LECTIN BINDING; MAJOR CLINICAL STUDY; MELANOCYTE; MELANOMA CELL; METASTASIS; PROGNOSIS; SIGNET RING CARCINOMA;

EID: 0032915963     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90201-0     Document Type: Article

References (38)

1. Zebda N, Bailly M, Brown S, et al: Expression of PNA-binding sites on specific glycoproteins by human melanoma cells is associated with a high metastatic potential. J Cell Biochem 54:161-173, 1994
2. Cochran AJ, Bailly C, Paul E, et al: Melanocytic Tumors: A Guide to Diagnosis. Philadelphia, PA, Lippincott-Raven, 1997
3. Cochran AJ: Method of assessing prognosis in patients with malignant melanoma. Lancet 2:1062-1064, 1968
4. Cochran AJ: Histology and prognosis in malignant melanoma. J Pathol 97:459-468, 1969
5. Mackie RM, Carfrae DC, Cochran AJ: The assessment of prognosis in patients with malignant melanoma. Lancet 2:456-458, 1972
6. Clark WH Jr, Elder DE, Guerry D IV, et al: A model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 81:1893-1904, 1989
7. Schuchter L, Schultz DL, Synnestvedt M, et al: A prognostic model for predicting 10 year survival in patients with primary melanoma. Ann Intern Med 125:369-375, 1996
8. Cochran AJ, Elashoff D, Morton DL, et al: Individual prognosis for melanoma patients. Mod Pathol 11:48A, 1998
9. Albeda SM, Mette SA, Elder DE, et al: Integrin distribution in malignant melanoma: Association of the β3 subunit with tumor progression. Cancer Res 50:6757-6764, 1990
10. Kageshita T, Yoshii A, Kimura T, et al: Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma. Cancer Res 53:6927-6932, 1993
11. Holzman B, Bröcker EB, Lehmenn JM, et al: Tumor progression in human malignant melanoma: Five stages denned by their antigenic phenotypes. Int J Cancer 39:666-671, 1987
12. Klein CE, Skinmayer T, Kaufmann D, et al: Identification of a melanoma progression antigen as integrin VLA-2. J Invest Dermotol 96:281-284, 1991
13. Johnson JP, Stade BG, Holzman B, et al: De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci 86:641-644, 1989
14. Berthier-Vergnes O, Zebda N, Bailly M, et al: Expression of peanut agglutinin-binding glycoconjugate in primary melanomas with high risk of metastases. Lancet 341:1292, 1993
15. Bailly M, Doré JF: Human tumor spontaneous metastasis in immunosuppressed new born rats: II. Multiple selections of human melanoma metastatic clones and variants. Int J Cancer 49:750-757, 1991
16. Berthier-Vergnes O, Berrux V, Rèano A, et al: Expression of cell surface sialic acid and galactose by normal adult human melanocytes in culture. Pigment Cell Res 3:55-60, 1990
17. Lotan R, Skutelsky E, Danon D, et al: The purification, composition and specificity of the anti-T lectin from peanut (Arachis hypogea). J Biol Chem 250:8518-8523, 1975
18. Berthier-Vergnes O, Portoukalian J, Doré J-F: Organization and neuraminidase susceptibility of sialic acid residues in human melanoma cell lines with different heterotransplantabilities in nude mice. J Natl Cancer Inst 75:606-611, 1985
19. Zebda N, Pedron S, Rebba A, et al: Deficiency of ganglioside biosynthesis in metastatic human melanoma cells: Relevance of CMP-Neu LacCer α 2,3 sialytransferase (GM3 Synthese). FEBS Lett 362:161-164, 1995
20. Dean AG, Dean JA, Coulombier D, et al: Epi Info. Version 6: A word processing data base and statistics program for epidemiology on microcomputers. Atlanta, GA, Centers for Disease Control and Prevention, 1994
21. Breslow A: Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172:902-908, 1970
22. Clark WH Jr: A classification of malignant melanoma in man correlated with histogenesis and clinical behavior, in Montagna W, Hu F (eds): Advances in the Biology of the Skin. New York, NY, Pergammon Press, 1976, pp 621-647
23. Springer GF: T and Tn general carcinoma autoantigens. Science 224:1198-1206, 1984
24. Springer GF, Desai PR, Tegtmeyer H, et al: Responses of patients to their carcinoma-associated T and Tn-specific antigens, in Cimino F, Birkmayer GD, Klavins JV, et al (eds): Human Tumor Markers, Proc 3rd Int Conference, Berlin-New York, Walter de Grugter, 1987, pp 315-332
25. Kellokumpu I, Kellokumpu S, Andersson LC: Identification of glycoproteins expressing tumor-associated PNA-binding sites in colorectal carcinomas by SDS-GEL electrophoresis and PNA-labelling. Br J Cancer 55:361-365, 1987
26. Otsuka K, Ohkuma S, Nakajima T, et al: Thomsen-Friedenrich (T)-active glycoproteins and a blood group N antigen precursor with T activity from human liver metastatic carcinomas. Naturwissenschaften 75:407-409, 1988
27. Hakomori SI: Aberrant glycosylation in tumors and tumors-associated carbohydrate antigens. Adv Cancer Res 52:257-270, 1989
28. Sata T, Roth J, Zuber C, et al: Expression of alpha 2,6 linked sialic acid residues in neoplastic, but not in normal human colonic mucosa: A lectin-gold cytochemical study with Sambucus Nigra and Maackia amurensis lectins. Am J Pathol 139:1435-1448, 1991
29. Kageshita T, Hirai S, Kimura T, et al: Association between sialyl Lewis (a) expression and tumor progression in melanoma. Cancer Res 55:1748-1751, 1995
30. Hakomori SI: Possible functions of tumor-associated carbohydrate antigens. Curr Opin Immunol 3:646-653, 1991
31. Ching CK, Rhodes JM: Purification and characterization of a peanut agglutinin binding pancreatic cancer-related serum mucus glycoprotein. Int J Cancer 45:1022-1027, 1990
32. Dennis JW: N-linked oligosaccharide processing and tumor cell biology. Oxford Glycosystems, Glyconews, 2, 1992
33. Sheibani K, Battifora H: Signet ring cell melanoma, a rare morphologic variant of malignant melanoma. Am J Surg Pathol 12:28-34, 1988
34. Bonetti F, Colombari R, Zamboni G, et al: Signet ring melanoma, S-100 negative. Am J Surg Pathol 13:522-523, 1989
35. Al-Talib RK, Theaker JM: Signet ring cell melanoma: Light microscopic immunohistochemical and ultrastructural features. Histopathology 18:572-575, 1991
36. Livolsi VA, Brooks JJ, Soslow R, et al: Signet cell melanocytic lesions. Mod Pathol 5:515-520, 1992
37. Hakomori S: Aberrant glycosylation of cancer cell membranes as focused on glycolipids: Overview and perspectives. Cancer Res 45:2405-2414, 1985
38. Doré J-F, Maisonneuve P, Cattaruzza MS, et al: A molecular epidemiological approach to the study of expression of a metastases marker in primary melanomas and its correlation with individual patient's risk of recurrence or metastasis. Melanoma Res 7:8121-125, 1997 (suppl 2)